Advertisement

Biochemical Markers for Human Leukemia and Cell Differentiation

  • P. S. Sarin
  • M. Virmani
  • P. Pantazis
  • R. C. Gallo
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 57)

Summary

Biological markers that can be utilized in following patients during treatment and remission and are differentiation specific have been examined. Two such markers are: (1) terminal deoxynucleotidyl transferase (TdT) and (2) a histone polypeptide (HP). TdT is a unique DNA polymerase that can carry out DNA synthesis on an initiator molecule in the absence of a template. The potential usefulness of this enzyme in predicting the onset of relapse before any morphological indications has been demonstrated in chronic myelogenous leukemia patients in blast phase of the disease. In order to be able to detect low levels of TdT activity especially during remission phase, we have used cell separation techniques which can enrich cell populations containing TdT activity. We have used the techniques of unit gravity sedimentation and free flow electrophoresis to achieve enrichment of TdT positive cell populations. Our results show that up to 30 fold enrichment of TdT activity in normal human bone marrow can be accomplished by using cell separation techniques. With the use of free flow electrophoresis, we have achieved enrichment of TdT positive cell populations from normal human bone marrow, cells from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia in blast phase of the disease. No TdT positive cells were detected in patients with acute myelogenous leukemia. These cell separation techniques should prove to be useful in early detection of relapse in patients in remission. A differentiation specific histone polypeptide (HP) with an apparent molecular weight of 12,500 has been identified among the acid extractable chromosomal proteins of a human myeloid cell line, HL60, treated with dimethyl sulfoxide (DMSO). The relative increase in the amount of HP in DMSO treated HL60 cells correlated with a concomitant decrease in histone H2A. Fingerprint analysis of tryptic digests shows HP and histone H2A are related, HP is generated from endogenous and exogenous H2A and is probably produced by a proteolytic enzyme associated with the chromatin of the differentiated HL60 cells. HP is not detected in a number of human or mouse hematopoietic tissues and cell lines. However, it is present in leukocytes from patients with acute leukemia. These results indicate that the observed level of HP in HL60 cells is related to the stage of differentiation and that HP is a potential biological markers for human acute leukemia.

Keywords

Acute Lymphoblastic Leukemia HL60 Cell Chronic Myelogenous Leukemia Acute Myelogenous Leukemia Terminal Deoxynucleotidyl Transferase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    F. J. Bollum, Terminal deoxynucleotidyl transferase, in: “The Enzymes” P. D. Boyer, ed., Academic Press, N.Y., p. 145 (1974).Google Scholar
  2. 2.
    P. S. Sarin, Terminal transferase as a biological marker for human leukemia, in: “Recent Studies in Cancer Research” R. Gallo, ed., CRC Press, Cleveland, p. 131 (1977).Google Scholar
  3. 3.
    R. McCaffrey, D. F. Smoler and D. Baltimore, Terminal deoxynucleotidyl transferase in a case of childhood acute lymphoblastic leukemia, Proc. Natl. Acad. Sci USA 70: 521 (1973).CrossRefGoogle Scholar
  4. 4.
    M. S. Coleman, J. J. Hutton, P. D. Simone, and F. J. Bollum, Terminal deoxynucletidyl transferase in human leukemia, Proc. Natl. Acad. Sci USA 71: 4404 (1974).CrossRefGoogle Scholar
  5. 5.
    S. Khan, J. Minowada, E. Henderson and I. Tabowski, Terminal deoxynucleotidyl transferase activity and blast cell characteristics in adult acute leukemias, Leukemia Res. 4: 209 (1980).CrossRefGoogle Scholar
  6. 6.
    P. S. Sarin and R. C. Gallo, Terminal deoxynucleotidyl transferase in chronic myelogenous leukemia, J. Biol. Chem. 249: 8051 (1974).Google Scholar
  7. 7.
    P. S. Sarin, P. N. Anderson and R. C. Gallo, Terminal deoxynucleotidyl transferase activities in human blood leukocytes and lymphoblast cell lines. High levels in lymphoblast cell lines and in blast cells of some patients with chronic myelogenous leukemia in acute phase, Blood 47: 11 (1976).Google Scholar
  8. 8.
    P. S. Sarin and R. C. Gallo, Terminal deoxynucleotidyl transferase as a biological marker in human leukemia, in: “Modern Trends in Human Leukemia” R. Neth, ed., J. F. Lehmann’s Verlag, Munich, Vol. 2, p. 491 (1976).CrossRefGoogle Scholar
  9. 9.
    R. McCaffrey, T. Harrison, R. Parkman and D. Baltimore, Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal human thymocytes, N. Engl. J. Med. 292: 775 (1975).CrossRefGoogle Scholar
  10. 10.
    M. S. Coleman, M. F. Greenwood, J. J. Hutton, F. J., Bollum, B. Lampkin and P. Holland, Serial observations on terminal deoxynucleotidyl transerase activity and lymphoblast surface marker in acute lymphoblastic leukemia, Cancer Res. 36: 120 (1976).Google Scholar
  11. 11.
    S. L. Marcus, S.W. Smith, C. L. Jarowski and M. J. Modak, Terminal deoxyribonucleotidyl transferase activity in acute undifferentiated leukemia, Biochem. Biophys. Res. Commun. 70: 37 (1976).CrossRefGoogle Scholar
  12. 12.
    B. Srivastava and J. Minowada, Terminal deoxynucleotidyl transferase in a cell line (Molt-4) derived from the peripheral blood of a patient with acute lymphoblastic leukemia, Biochem. Biophys. Res. Commun. 51: 529 (1973).CrossRefGoogle Scholar
  13. 13.
    P. S. Sarin and R. C. Gallo, Characterization of terminal deoxynucleotidyl transferase in a cell line (8402) derived from a patient with acute lymphoblastic leukemia, Biochem. Biophys. Res. Commun. 76: 673 (1975).CrossRefGoogle Scholar
  14. 14.
    J. C. F. Schubert, F. Walther, E. Holzberg, G. Pascher and K. Zeiller, Preparative electrophoretic separation of normal and neoplastic bone marrow cells, Klin. Wschr. 51: 327 (1973).CrossRefGoogle Scholar
  15. 15.
    K. Zeiller, J. C. F. Schubert, F. Walther and K. Hanning, Electrophoretic distribution analysis of in vivo colony forming cells in mouse bone marrow, Hoppe-Seyler’s Z. Physiol. Chem. 353: 95 (1972).CrossRefGoogle Scholar
  16. 16.
    K. Hanning and H. G. Heidrich, The use of continuous preparative free flow electrophoresis for dissociating cell fractions and isolation of membranous components, in: “Methods in Enzymology” S. Fleischer and L. Packer, L. eds., Academic Press, New York, Vol. 31, p. 746 (1974).Google Scholar
  17. 17.
    R. Axel, W. Melchoir, B. Sollner-Webb and G. Felsenfeld, Specific sites of interaction between his tones and DNA in chromatin, Proc. Natl. Acad. Sci. USA 71: 4101 (1974).CrossRefGoogle Scholar
  18. 18.
    G. Felsenfeld, Chromatin, Nature 271: 115 (1978).CrossRefGoogle Scholar
  19. 19.
    R. E. Kornberg and J. D. Thomas, Chromatin structure: oligomers of the histones, Science 184: 865 (1974).CrossRefGoogle Scholar
  20. 20.
    A. Zweidler, M. Urban and P. Goldman, The origin and significance of tissue-specific histone variant patterns in mammals, in: “Miami Winter Symposia”, F. Ahmad, T. R. Russel, J. Schultz and R. Werner, eds., Academic Press, New York, Vol. 15, p. 531 (1978).Google Scholar
  21. 21.
    L. A. Blankenstein and S. B. Levy, Changes in histone F2A2 associated with proliferation of Friend leukemic cells, Nature 260: 638 (1976).CrossRefGoogle Scholar
  22. 22.
    S.J. Collins, F. W. Ruscetti, R. E. Gallagher and R. C. Gallo, Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds, Proc. Natl. Acad. Sci. USA 75: 2458 (1978).CrossRefGoogle Scholar
  23. 23.
    R. H. Rice and G. E. Means, Radioactive labeling of proteins in vitro, J. Biol. Chem. 246: 831 (1971).Google Scholar
  24. 24.
    C. B. Lozzio and B. B. Lozzio, Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome, Blood 43: 321 (1975).Google Scholar
  25. 25.
    C. Friend, W. Scher, J. G. Holland and T. Sato, Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide, Proc. Natl. Acad. Sci. USA 68: 378 (1971).Google Scholar
  26. 26.
    P. Pantazis, P. S. Sarin and R. C. Gallo, Detection of a histone-2A related polypeptide in differentiated human myeloid cells (HL-60) and its distribution in human acute leukemia, Int. J. Cancer 27: 585 (1981).CrossRefGoogle Scholar
  27. 27.
    J. H. Elder, F. C. Jensen, H. L. Bryant and R. A. Lerner, Polymorphism of the major envelope glycoproteins (gp70) of murine C-type viruses: virions associated with differentiation antigens encoded by multi-gene family, Nature 267: 23 (1977).CrossRefGoogle Scholar
  28. 28.
    R. D. Barr, P. S. Sarin and S. Perry, Terminal transferase in human bone marrow lymphocytes, Lancet 1: 508 (1976).CrossRefGoogle Scholar
  29. 29.
    M. M. Oken, P. S. Sarin, R. C. Gallo, et al. Terminal transferase levels in chronic myelogenous leukemia in blast crisis and in remission, Leukemia Res. 2: 173 (1978).CrossRefGoogle Scholar
  30. 30.
    D. D. Ross, P. H. Wiernik, P. S. Sarin and J. Whang-Peng, Loss of terminal deoxynucleotidyl transferase activity as a predictor of emergence of resistance to chemotherapy in a case of chronic myelogenous leukemia, Cancer 44: 1566 (1979).CrossRefGoogle Scholar
  31. 31.
    D. R. Boggs, Hematopoietic stem cell theory in relation to possible lymphoblastic conversion of chronic myeloid leukemia, Blood 44: 449 (1974).Google Scholar
  32. 32.
    G. P. Canellos, V. T. DeVita, J. Whang-Peng and P. P. Carbone, Hematologic and cytogenetic remission of biastic transformation in chronic granulocytic leukemia, Blood 38: 671 (1971).Google Scholar
  33. 33.
    S. M. Marks, D. Baltimore and R. McCaffrey, Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blast crisis myelogenous leukemia. New Eng. J. Med. 298: 812 (1978).CrossRefGoogle Scholar
  34. 34.
    L. Cohen, K. Newrock and A. Zweidler, Stage-specific switches in histone synthesis during embryogenesis of the sea urchin, Science 190: 994 (1975).CrossRefGoogle Scholar
  35. 35.
    H. Imoh, Re-examination of histone changes during development of newt embryos, Exp. Cell Res. 113: 23 (1978).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • P. S. Sarin
    • 1
  • M. Virmani
    • 1
  • P. Pantazis
    • 1
  • R. C. Gallo
    • 1
  1. 1.Laboratory of Tumor Cell BiologyNational Cancer InstituteBethesdaUSA

Personalised recommendations